Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-21-017682

EVP, Chief Technology Officer sold 92 shares at $55.19 ($5,077)

  • EVP, Chief Technology Officer acquired 10,605 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lingamneni Anila · EVP, Chief Technology Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-18 Grant or award : show line 1 in the form +3,535 7,224 D
2021-05-18 Grant or award : show line 2 in the form +7,070 14,294 D
2021-05-19 Sale : show line 3 in the form −92 $55.19 $5,077 14,202 D
Open-market sales · 92 sh · avg $55.19 · $5,077

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-18 Grant or award : show line 4 in the form Non-qualified Stock Option (Right to Buy) +9,564 9,564 D
Loading xslF345X03/form4.xml…